Acute and Postacute Health Care Utilization and Costs After Dengue Infection: A Population-Based Cohort Study - Scorecard - MDSpire

Acute and Postacute Health Care Utilization and Costs After Dengue Infection: A Population-Based Cohort Study

  • By

  • Jue Tao Lim

  • Liang En Wee

  • Wei Zhi Tan

  • Calvin Chiew

  • Lalitha Kurupatham

  • Cuiqin Poh

  • Nur-Afidah Md Suhaimi

  • Hui Zi Chua

  • Lee Ching Ng

  • Po Ying Chia

  • David Chien Boon Lye

  • Kelvin Bryan Tan

  • July 3, 2025

  • 0 min

Share

Clinical Scorecard: Health Care Usage and Expenses Following Acute and Postacute Dengue Infection: A Cohort Analysis Based on Population Data

At a Glance

CategoryDetail
ConditionDengue infection with acute and postacute phases
Key MechanismsIncreased health care utilization and costs due to acute infection and postacute sequelae
Target PopulationAdults (≥18 years) in Singapore infected with dengue
Care SettingPublic hospitals and emergency departments in Singapore

Key Highlights

  • Dengue patients have elevated risk of emergency department visits, inpatient admissions, and inpatient costs during acute (0–30 days) and postacute (31–300 days) periods.
  • Among admitted patients, dengue infection is associated with significantly higher rates and longer lengths of inpatient and ICU stays compared to population controls.
  • Majority of excess health care costs occur during the acute phase (over US$21 million) compared to the postacute period (approximately US$687,000).

Guideline-Based Recommendations

Diagnosis

  • Confirm dengue infection using NS1 antigen assays or immunoglobulin M enzyme-linked immunoassay.
  • Report dengue cases to Ministry of Health within 24 hours of clinical diagnosis or laboratory confirmation.

Management

  • Monitor patients for acute symptoms and provide appropriate inpatient or ICU care as needed.
  • Recognize potential for postacute sequelae and plan follow-up care accordingly.

Monitoring & Follow-up

  • Track health care utilization including emergency department visits, hospital admissions, and ICU stays up to 300 days post-infection.
  • Exclude patients with SARS-CoV-2 infection within 300 days to avoid confounding long-term sequelae.

Risks

  • Increased risk of long-term health care utilization and costs due to postacute dengue sequelae.
  • Potential for multisystemic chronic symptoms similar to other viral infections.

Patient & Prescribing Data

Adults with laboratory-confirmed dengue infection in Singapore

Health care utilization and costs are substantially elevated in both acute and postacute phases, indicating need for resource planning and long-term patient monitoring.

Clinical Best Practices

  • Utilize national notification systems for timely dengue diagnosis and reporting.
  • Implement matched population controls for accurate assessment of dengue-related health care burden.
  • Plan health care resources to address both acute treatment and postacute sequelae management.
  • Exclude confounding infections such as COVID-19 when evaluating postinfectious sequelae.

References

Original Source(s)

Related Content